Synergy Pharmaceuticals Announces Exercise of Remainder of Over-Allotment Option by Aegis Capital Corp. Bringing Total Gross Proceeds to $51.75 Million

Synergy Pharmaceuticals Inc.

announced the exercise of the remainder of the over-allotment option granted to the underwriters with respect to the purchase of 750,000 shares of common stock at a public offering price of $4.50 per share, in connection with its previously announced underwritten public offering of 10,000,000 shares of common stock, bringing total gross proceeds from the offering to $51,750,000. Aegis Capital Corp. acted as the sole book-running manager for the offering.